You are here
QT Vascular's Q2 loss widens on expenses
BALLOONING administrative and research and development expenses caused Catalist-listed QT Vascular's net loss for the quarter ended June to widen, from US$11.4 million to US$13.5 million even as revenue tripled. For the second quarter, revenue rose from US$1.03 million to US$3.23 million.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org